Lemonade is transforming insurance with AI-driven risk assessment and claim payouts. See why LMND stock is a top pick for ...

QIAGEN N.V. today announced that it has filed a complaint against bioMérieux S.A. (EPA: BIM) for patent infringement, reinforcing its commitment to protecting the scientific advancements behind its ...

Consumer stocks have gained 23 per cent this year, according to one Hang Seng yardstick, as DeepSeek helped with a broader ...

China's central bank, together with other top financial regulators, convened a high-level symposium on Friday to discuss ...

China's central bank and financial regulators held a meeting with private enterprises and financial institutions, vowing to ...

The U.S. Securities and Exchange Commission (SEC) has recently changed its overall approach to crypto-related enforcement ...

About Fabhalta® (iptacopan) Fabhalta (iptacopan) is an oral, Factor B inhibitor of the alternative complement pathway 6-7.

We assess Interactive Brokers' balance sheet as very healthy, with no long-term debt and minimal short-term borrowings at the end of 2024. We are confident that the company can easily meet interest ...

Going case by case, regulators have halted investigations and withdrawn or paused lawsuits against top crypto companies and ...

Beijing isn't going to allow crypto exchanges to directly operate BTC in China, but there might be a way that Hong Kong ...